Search Results - "thrombocytopenia"

Pediatric Severe Febrile Thrombocytopenia Syndrome: A Case Report and Literature Review.

Toyota Y; Department of Pediatrics, NHO Iwakuni Clinical Center.; Department of Pediatrics, Okayama University Hospital., Uda K; Department of Pediatrics, NHO Iwakuni Clinical Center.; Department of Pediatrics, Okayama University Hospital., Shirabe K; Yamaguchi Prefectural Institute of Public Health and Environment., Moriwake T; Department of Pediatrics, NHO Iwakuni Clinical Center.

Case Reports; Journal Article; Review , 2024

Procalcitonin levels in severe fever with thrombocytopenia syndrome patients: a retrospective investigation in Anhui, China.

Wang W; Department of Infectious Diseases, The First Affiliated Hospital of Wannan Medical College, Wuhu 241001, Anhui, PR China., Yang Y; Department of Stomatology, Bengbu Medical College, Bengbu, Anhui 233000, PR China., Liang M; Department of Infectious Diseases, The First Affiliated Hospital of Wannan Medical College, Wuhu 241001, Anhui, PR China., Zhang A; Department of Infectious Diseases, The First Affiliated Hospital of Wannan Medical College, Wuhu 241001, Anhui, PR China., Zhang Z; Department of Infectious Diseases, Chaohu Hospital of Anhui Medical University, HeFei 238000, Anhui, PR China., Yang J; Department of Infectious Diseases, The First Affiliated Hospital of Wannan Medical College, Wuhu 241001, Anhui, PR China.

Journal Article , 2024

Transmission of Severe Fever with Thrombocytopenia Syndrome (SFTS) to humans: A systematic review of individual participant data and meta-analysis.

Woo D; Graduate School of Urban Public Health, University of Seoul, Seoul, Republic of Korea; Department of Urban Big Data Convergence, University of Seoul, Seoul, Republic of Korea; Accountable Care Hospital Connected Care Support Team, Center for Public Healthcare, National Medical Center, Seoul, Republic of Korea., Michelow IC; Department of Pediatrics, Division of Infectious Diseases and Immunology, Connecticut Children's and University of Connecticut School of Medicine, Hartford, CT, United States., Choi Y; Graduate School of Urban Public Health, University of Seoul, Seoul, Republic of Korea., Lee H; Graduate School of Urban Public Health, University of Seoul, Seoul, Republic of Korea; Department of Urban Big Data Convergence, University of Seoul, Seoul, Republic of Korea., Park S; Graduate School of Urban Public Health, University of Seoul, Seoul, Republic of Korea; Department of Urban Big Data Convergence, University of Seoul, Seoul, Republic of Korea. Electronic address: dvm.spark@gmail.com.

Journal Article; Systematic Review; Meta-Analysis; Review , 2025

Acquired Amegakaryocytic Thrombocytopenia with Glycoprotein IIb/IIIa Antibody in a Patient with Mantle Cell Lymphoma.

Sato K; Department of Hematology, Nagano Red Cross Hospital, Japan., Ueki T; Department of Hematology, Nagano Red Cross Hospital, Japan., Tokutake T; Department of Clinical Laboratory, Nagano Red Cross Hospital, Japan., Ueno M; Department of Clinical Oncology, Nagano Red Cross Hospital, Japan., Ichikawa N; Department of Clinical Oncology, Nagano Red Cross Hospital, Japan., Sumi M; Department of Hematology, Nagano Red Cross Hospital, Japan., Kobayashi H; Department of Hematology, Nagano Red Cross Hospital, Japan.

Journal Article; Case Reports , 2025

Clinical characteristics, and outcomes of severe neonatal thrombocytopenia: a retrospective cohort study in China.

Shan Y; Department of Pediatric Intensive Care Unit, National Children's Medical Center, Children's Hospital of Fudan University, Shanghai, China., Peng T; Department of Neonatology, National Children's Medical Center, Children's Hospital of Fudan University, Shanghai, China., Zhang P; Department of Neonatology, National Children's Medical Center, Children's Hospital of Fudan University, Shanghai, China., Cheng G; Department of Neonatology, National Children's Medical Center, Children's Hospital of Fudan University, Shanghai, China. gqcheng_cm@fudan.edu.cn.; Fujian Key Laboratory of Neonatal Diseases, Xiamen Children's Hospital, 92 Yibin Road, Xiamen, Fujian, 361000, China. gqcheng_cm@fudan.edu.cn.

Journal Article , 2025

[Refractory immune thrombocytopenia revealing MYH9 related disease in a 64-year-old man].

Bodard Q; Service de médecine interne, maladies infectieuses et rhumatologie, centre hospitalier d'Angoulême, Angoulême, France. Electronic address: quentin.bodard@ch-angouleme.fr., Fredon G; Service de médecine interne, maladies infectieuses et rhumatologie, centre hospitalier d'Angoulême, Angoulême, France., Riche A; Service de médecine interne, maladies infectieuses et rhumatologie, centre hospitalier d'Angoulême, Angoulême, France., Tessier X; Laboratoire de biologie médicale, centre hospitalier d'Angoulême, Angoulême, France., Liberatore J; Service de médecine interne, maladies infectieuses et rhumatologie, centre hospitalier d'Angoulême, Angoulême, France.

Journal Article; Case Reports; English Abstract , 2025

Chemotherapy-induced thrombocytopenia: modern diagnosis and treatment.

Song AB; Harvard Medical School, Boston, Massachusetts, USA.; Division of Hematology Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA., Al-Samkari H; Harvard Medical School, Boston, Massachusetts, USA.; Division of Hematology Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA.

Journal Article; Review , 2025

Elevated CD4 ^- CD8 ^- double-negative T cells in the peripheral blood of SFTS patients are associated with disease severity.

Qiu PP; Department of Clinical Laboratory Medicine, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China., Cai SJ; Department of Clinical Laboratory Medicine, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, Nanjing, China., Guo LL; Department of Clinical Laboratory Medicine, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China., Hu W; Department of Clinical Laboratory Medicine, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China., Song HY; Department of Clinical Laboratory Medicine, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China., Huang TH; Department of Clinical Laboratory Medicine, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China; Department of Clinical Laboratory Medicine, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University, Nanjing, China. Electronic address: 1262117241@qq.com., Xu ZY; Department of Clinical Laboratory Medicine, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China. Electronic address: xuzhiye@sina.com., Wang S; Department of Clinical Laboratory Medicine, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China; Department of Clinical Laboratory Medicine, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, Nanjing, China. Electronic address: njwangsen@163.com.

Journal Article , 2025

Prospective multicenter comparison of the diagnostic value of IgG and IgGAM antibodies for heparin-induced thrombocytopenia.

Zhang W; Department of Clinical Laboratory, Beijing Jishuitan Hospital, Capital Medical University, Beijing, China., Feng R; Department of Laboratory Medicine, Wuhan Asia Heart Hospital, Wuhan, Hubei, China., Su Y; Department of Clinical Laboratory, Beijing Jishuitan Hospital, Capital Medical University, Beijing, China. Electronic address: suyu_jst@yeah.net., Kang J; Department of Clinical Laboratory, Beijing Jishuitan Hospital, Capital Medical University, Beijing, China., Yao Y; Department of Clinical Laboratory, Beijing Jishuitan Hospital, Capital Medical University, Beijing, China., Zhao H; Department of Clinical Laboratory, Beijing Jishuitan Hospital, Capital Medical University, Beijing, China., Cao X; Department of Clinical Laboratory, Beijing Jishuitan Hospital, Capital Medical University, Beijing, China. Electronic address: xingyu417@sina.com., Fan Q; Department of Laboratory Medicine, Wuhan Asia Heart Hospital, Wuhan, Hubei, China. Electronic address: fqk@wahh.com.cn., Wu J; Department of Clinical Laboratory, Beijing Jishuitan Hospital, Capital Medical University, Beijing, China. Electronic address: wujunpostbox@sina.com.

Journal Article; Multicenter Study; Comparative Study , 2025

Evaluation of a rapid immunochromatographic diagnostic test for heparin-induced thrombocytopenia: validation of delayed test and whole blood test.

Billoir P; Normandie Univ, UNIROUEN, INSERM U1096, CHU Rouen, Vascular Hemostasis Unit, F-76000 Rouen, France. Electronic address: paul.billoir@chu-rouen.fr., Barbay V; CHU Rouen, Vascular Hemostasis Unit, F-76000 Rouen, France., Fresel M; CHU Rouen, Vascular Hemostasis Unit, F-76000 Rouen, France., Brunel S; CHU Rouen, Vascular Hemostasis Unit, F-76000 Rouen, France., Le Cam Duchez V; Normandie Univ, UNIROUEN, INSERM U1096, CHU Rouen, Vascular Hemostasis Unit, F-76000 Rouen, France.

Journal Article; Validation Study; Evaluation Study , 2025

Development of antibodies against severe fever with thrombocytopenia syndrome virus nucleoprotein for diagnosis.

Park EM; Division of Research Center, Scripps Korea Antibody Institute, Chuncheon, 24341, Republic of Korea., Kim S; Division of Research Center, Scripps Korea Antibody Institute, Chuncheon, 24341, Republic of Korea., Lim S; Division of Research Center, Scripps Korea Antibody Institute, Chuncheon, 24341, Republic of Korea., Rahimizadeh P; Division of Research Center, Scripps Korea Antibody Institute, Chuncheon, 24341, Republic of Korea., Jeon H; Division of Research Center, Scripps Korea Antibody Institute, Chuncheon, 24341, Republic of Korea., Lim HJ; Division of Research Center, Scripps Korea Antibody Institute, Chuncheon, 24341, Republic of Korea., Lee S; Division of Research Center, Scripps Korea Antibody Institute, Chuncheon, 24341, Republic of Korea., Song YB; Division of Research Center, Scripps Korea Antibody Institute, Chuncheon, 24341, Republic of Korea. songyb8686@gmail.com.

Journal Article , 2025

Lactate Dehydrogenase/Albumin to Urea Ratio: A Novel Prognostic Indicator for Adverse Outcomes in Patients With Severe Fever With Thrombocytopenia Syndrome.

Zhang R; National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, China.; Department of Infectious Disease, Beijing Ditan Hospital, Capital Medical University, Beijing, China.; Beijing Research Center for Respiratory Infectious Diseases, Beijing, China., Mu Y; National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, China., Zhang M; National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, China.; Beijing Key Laboratory of Emerging Infectious Diseases, Institute of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, China.; Beijing Institute of Infectious Diseases, Beijing, China.; National Center for Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, China., Wu H; National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, China., Xu Y; Department of Infectious Diseases, Yantai Qishan Hospital, Yantai, China., Zhao C; National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, China., Liu Z; Department of Gastroenterology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China., Lin L; Department of Infectious Diseases, Yantai Qishan Hospital, Yantai, China., Zhang W; National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, China., Kong Y; National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, China.; Beijing Key Laboratory of Emerging Infectious Diseases, Institute of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, China.; Beijing Institute of Infectious Diseases, Beijing, China.; National Center for Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, China., Chen Z; National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, China.; Department of Infectious Disease, Beijing Ditan Hospital, Capital Medical University, Beijing, China.; Beijing Research Center for Respiratory Infectious Diseases, Beijing, China.

Journal Article , 2025

Risk of Thrombocytopenia by SSRIs or SNRIs in Patients With Depression Based on MID-NET: A Cohort Study in Japan.

Okada Y; Office of Pharmacovigilance I, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan.; Office of Pharmacovigilance II, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan., Kajiyama K; Office of Pharmacovigilance I, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan.; Office of Pharmacovigilance II, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan.; Office of Regulatory Science Research, Center for Regulatory Science, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan., Komamine M; Office of Pharmacovigilance I, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan.; Office of Pharmacovigilance II, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan., Ando T; Office of Pharmacovigilance I, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan.; Office of Pharmacovigilance II, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan., Hasegawa T; Office of Pharmacovigilance I, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan.; Office of Pharmacovigilance II, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan., Ishiguro C; Office of Medical Informatics and Epidemiology, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan., Nonaka T; Office of Medical Informatics and Epidemiology, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan., Tsukuda M; Office of Pharmacovigilance II, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan., Iwasaki Y; Office of Pharmacovigilance II, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan., Ueda T; Office of Pharmacovigilance II, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan., Horiuchi N; Office of Pharmacovigilance I, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan., Iguchi T; Office of Pharmacovigilance II, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan., Uyama Y; Office of Medical Informatics and Epidemiology, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan.; Center for Regulatory Science, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan.

Journal Article; Observational Study; Comparative Study , 2025

Management of thrombocytopenia and anticoagulant therapy in patients with hematological malignancy on chemotherapy: a binational prospective study (TAT study).

Jalaber E; Hematology Department, Cancer Institute of University Hospital of Saint-Etienne, Saint-Etienne, France.; Intensive Care Unit, University Hospital of Rennes, Rennes, France., Orvain C; Hematology Department, University Hospital of Angers, Angers, France.; Fédération Hospitalo-Universitaire Grand-Ouest Acute Leukaemia, FHU-GOAL, Angers Cedex, France.; University of Angers, Inserm UMR 1307, CNRS UMR 6075, Nantes University, CRCI2NA, 49000, Angers, France., Papadopoulou V; Hematology Department, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.; Oncology/Hematology Department, University Hospital of Zurich, Zurich, Switzerland., Genthon A; Hematology Department, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.; Hematology Department, APHP, Saint Antoine, Paris, France., Daguerre V; Hematology Department, Cancer Institute of University Hospital of Saint-Etienne, Saint-Etienne, France., Barrière S; Hematology Department, University Hospital of Clermont Ferrand, Clermont-Ferrand, France., Teste A; Hematology Department, University Hospital of Clermont Ferrand, Clermont-Ferrand, France.; Hematology Department, Hospital Center Alpes Leman, Contamines-Sur-Arve, France., Tavernier E; Hematology Department, Cancer Institute of University Hospital of Saint-Etienne, Saint-Etienne, France., Daguenet E; Hematology Department, Cancer Institute of University Hospital of Saint-Etienne, Saint-Etienne, France., Chalayer E; Hematology Department, Cancer Institute of University Hospital of Saint-Etienne, Saint-Etienne, France. emilie.chalayer@chu-st-etienne.fr.; University Jean Monnet Saint-Etienne, CHU Saint-Etienne, Inserm, CIC1408, Inserm, SAINBIOSE-U1059, 42023, Saint-Etienne, France. emilie.chalayer@chu-st-etienne.fr.

Journal Article; Multicenter Study , 2025

Predictors of platelet count response following intravenous immunoglobulin use for maternal thrombocytopenia.

Khalife R; Department of Medicine, University of Ottawa, Ottawa, ON, Canada; Ottawa Hospital Research Institute, Ottawa, ON, Canada; Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada. Electronic address: rkhalife@toh.ca., Niu B; Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada., Perelman I; Ottawa Hospital Research Institute, Ottawa, ON, Canada., El-Chaâr D; Ottawa Hospital Research Institute, Ottawa, ON, Canada; Department of Obstetrics and Gynecology, University of Ottawa, Ottawa, ON, Canada., Fergusson D; Department of Medicine, University of Ottawa, Ottawa, ON, Canada; Ottawa Hospital Research Institute, Ottawa, ON, Canada; Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada., Karovitch A; Department of Medicine, University of Ottawa, Ottawa, ON, Canada; Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada; Department of Obstetrics and Gynecology, University of Ottawa, Ottawa, ON, Canada., Mack J; Department of Medicine, McGill University, Montreal, QC, Canada; Canadian Blood Services, Ontario, Canada., Tokessy M; Eastern Ontario Regional Laboratory Association, Ottawa Hospital, Ottawa, ON, Canada., Webert KE; Department of Medicine and the Department of Molecular Medicine and Pathology, McMaster University, Hamilton, ON, Canada; Canadian Blood Services, Ontario, Canada., Tinmouth A; Department of Medicine, University of Ottawa, Ottawa, ON, Canada; Ottawa Hospital Research Institute, Ottawa, ON, Canada; Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada; Canadian Blood Services, Ontario, Canada.

Journal Article , 2025

Refractory delayed-onset heparin induced thrombocytopenia (HIT) without thrombosis, treated with intravenous immunoglobulin.

Tomac G; Department of Transfusion Medicine and Transplantation Biology, University Hospital Centre Zagreb, Zagreb, Croatia. Electronic address: gordana.tomac@kbc-zagreb.hr., Horvat I; Department of Transfusion Medicine and Transplantation Biology, University Hospital Centre Zagreb, Zagreb, Croatia., Babel J; Division of Intensive Care Medicine, Department of Internal Medicine, Zagreb, University Hospital Center Zagreb, Croatia., Gojčeta K; Department of Transfusion Medicine and Transplantation Biology, University Hospital Centre Zagreb, Zagreb, Croatia., Liker M; Department of Transfusion Medicine and Transplantation Biology, University Hospital Centre Zagreb, Zagreb, Croatia., Boban A; Division of Hematology, Department of Internal Medicine, Zagreb, University Hospital Center Zagreb, Croatia; School of Medicine, University of Zagreb, Croatia., Bojanić I; Department of Transfusion Medicine and Transplantation Biology, University Hospital Centre Zagreb, Zagreb, Croatia; School of Medicine, University of Zagreb, Croatia; University of Applied Health Sciences, Zagreb, Croatia.

Journal Article; Case Reports , 2025

Persistent neonatal alloimmune thrombocytopenia caused by triple anti-HLA-A11, -B3901, and -Cw7 antibodies.

Hatano S; Department of Pediatrics, Fukushima Medical University School of Medicine, 1 Hikarigaoka, Fukushima, 960-1295, Japan., Maeda H; Department of Pediatrics, Fukushima Medical University School of Medicine, 1 Hikarigaoka, Fukushima, 960-1295, Japan. hmaeda@fmu.ac.jp., Ichikawa H; Department of Pediatrics, Fukushima Medical University School of Medicine, 1 Hikarigaoka, Fukushima, 960-1295, Japan., Ogasawara K; Department of Pediatrics, Fukushima Medical University School of Medicine, 1 Hikarigaoka, Fukushima, 960-1295, Japan., Takano N; Department of Blood Transfusion and Transplantation Immunology, Fukushima Medical University School of Medicine, Fukushima, Japan., Rikimaru S; Department of Blood Transfusion and Transplantation Immunology, Fukushima Medical University School of Medicine, Fukushima, Japan., Kawabata K; Department of Blood Transfusion and Transplantation Immunology, Fukushima Medical University School of Medicine, Fukushima, Japan., Ikeda K; Department of Blood Transfusion and Transplantation Immunology, Fukushima Medical University School of Medicine, Fukushima, Japan., Ohto H; Fukushima Medical University, Fukushima, Japan., Go H; Department of Pediatrics, Fukushima Medical University School of Medicine, 1 Hikarigaoka, Fukushima, 960-1295, Japan.

Journal Article; Case Reports , 2025

Neonatal Jk ^a hemolytic disease combined with alloimmune thrombocytopenia with extreme anemia: a case report with literature review.

Luo F; Department of Neonatology, Guangdong Women and Children Hospital, Guangzhou, China., Chen S; Department of Laboratory, Baoan Women's and Children's Hospital, Shenzhen, China., Li W; Department of Neonatology, Baoan Women's and Children's Hospital, Shenzhen, Guangdong, China., Zhou P; Department of Neonatology, Baoan Women's and Children's Hospital, Shenzhen, Guangdong, China. xianggalao@126.com.

Journal Article; Case Reports; Review , 2025

Predictive factors for persistent thrombocytopenia after peptide receptor radioligand therapy in enteropancreatic neuroendocrine tumors.

Ferrara R; Department of Nuclear Medicine, Institut Paoli-Calmettes, ENETS Center of Excellence, IPC NET Center, Marseille, France., Zemmour C; Department of Clinical Research and Investigation, Biostatistics and Methodology Unit, Institut Paoli-Calmettes, Marseille, France., Reichert T; Department of Nuclear Medicine, Institut Paoli-Calmettes, ENETS Center of Excellence, IPC NET Center, Marseille, France., Ouk D; Department of Nuclear Medicine, Institut Paoli-Calmettes, ENETS Center of Excellence, IPC NET Center, Marseille, France., Niccoli P; Department of Medical Oncology, Institut Paoli-Calmettes, ENETS Center of Excellence, IPC NET Center, Marseille, France., Maniry-Quellier J; Department of Medical Oncology, Institut Paoli-Calmettes, ENETS Center of Excellence, IPC NET Center, Marseille, France., Brenot-Rossi I; Department of Nuclear Medicine, Institut Paoli-Calmettes, ENETS Center of Excellence, IPC NET Center, Marseille, France., Charrier N; Department of Nuclear Medicine, Institut Paoli-Calmettes, ENETS Center of Excellence, IPC NET Center, Marseille, France., Oziel-Taieb S; Department of Medical Oncology, Institut Paoli-Calmettes, ENETS Center of Excellence, IPC NET Center, Marseille, France.

Journal Article , 2025

Fatal risk factors and the efficacy of glucocorticoid therapy in severe fever with thrombocytopenia syndrome: a multicenter retrospective cohort study.

Zhong F; School of Public Health, Nanjing Medical University, Nanjing, China., Zhang S; Department of Infectious Disease, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China., Zheng C; School of Public Health, Nanjing Medical University, Nanjing, China., Zhayier D; Department of Infectious Disease, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China., Liu S; Department of Infectious Disease, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China., You Q; School of Public Health, Nanjing Medical University, Nanjing, China., Huang H; Department of Infectious Disease, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China., Zhu B; Department of Infectious Disease, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China., Tian J; Department of Infectious Disease, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China., Hu Z; Department of Infectious Disease, the Second Hospital of Nanjing, School of Public Health, Nanjing Medical University, Nanjing, China.; Nanjing Hospital, Nanjing University of Chinese Medicine, Nanjing, China.; Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China., Zheng X; Department of Infectious Disease, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China., Wang B; Department of Infectious Disease, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China., Peng Z; School of Public Health, Nanjing Medical University, Nanjing, China.; National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, Chinese Center for Disease Control and Prevention, Beijing, China.; Chinese Center for Disease Control and Prevention, Beijing, China.

Journal Article; Multicenter Study , 2025